3l16
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 3l16 is ON HOLD Authors: Wiesmann, C., Sutherlin, D.P., Sampath, D., Berry, M., Castanedo, G., Heffron, T., Zhu, B-Y., Lewis, C., Olivero, A. Descr...) |
|||
| Line 3: | Line 3: | ||
The entry 3l16 is ON HOLD | The entry 3l16 is ON HOLD | ||
| - | Authors: | + | Authors: Murray, J.M., Wiesmann, C. |
Description: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer | Description: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 23 09:25:25 2009'' |
Revision as of 07:25, 23 December 2009
Unreleased structure
The entry 3l16 is ON HOLD
Authors: Murray, J.M., Wiesmann, C.
Description: Discovery of (thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer
Page seeded by OCA on Wed Dec 23 09:25:25 2009
